Feb 23, 2021
Egypt officials: Death toll from lake shipwreck climbs to 9
This news has been received from: wtop.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
CAIRO (AP) — Rescue workers were still searching Tuesday for at least five people who went missing in a shipwreck a lake near Egypt’s Mediterranean city of Alexandria. So far, nine people, including three children, were known to be dead, ambulance officials said.
The boat was carrying at least 19 people and capsized late Monday in the Lake of Mariut, while returning from an entertaining voyage, they said.
Rescue workers retrieved at least nine bodies, including children ages 1, 1 1/2 and 4 years old, and were searching for others, the ambulance officials said.
At least five people were rescued and were taken to hospitals, said the officials who spoke on condition of anonymity because they were not authorized to brief journalist.
Any survivors still in the lake, located west of located is located west of the city of Alexandria, could go into shock as temperatures fell Tuesday in the already cold waters.
Relatives spent the night on the shoreline, hoping their loved ones could be rescued or their bodies retrieved. Calls for volunteer divers to help searching were circulated on social media.
Citing relatives, local media reported that the victims, all from the same family, were returning from a voyage to an island in the lake. The victims arrived on the island in two groups, and they were all packed on the boat in their return, the privately-owned Al-Masry Al-Youm daily reported.
Alexandria’s governor, Mohammed el-Sharif, said in comments late Monday the boat was small and overcrowded, suggesting a possible cause of capsizing.
Most boats on the lake work without licenses, he said.
Copyright © 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
News Source: wtop.com
COVID-19 antibodies appear to protect survivors from getting reinfected for at least three months, new NIH study finds
What's more, this protection lasted for at least 90 days after their first antibody test, and in some cases even longer.
The team, from the National Cancer Institute at the National Institutes of Health, the findings are encouraging but that more research is needed to determine how long survivors are protected and if this protections is threatened by new coronavirus variants spreading across the U.S.
A new study looked at 3.2 million antibody tests January 2020 and August 2020. and found that 11.6% tested positive for coronavirus antibodies, and the remaining 88.4% tested negative. Pictured: A phlebotomist takes blood through a finger prick during a COVID-19 antibody test in Pico Rivera, California, February 2021
After at least 90 days, 0.3% of survivors were reinfected with COVID-19 compared to 3% of people who did not have antibodies (above, far right)
Antibody tests, also known as seropositivity tests, require blood to be collected through a vein, and can only be analyzed in a certified laboratory.
Some tests look for the IgG antibody, a protein that the body produces in the late stages of infection and may remain for up to months and possibly years after a person has recovered.
Others try detecting the antibody, IgM, which is made by the body a few days after infection.
'The data from this study suggest that people who have a positive result from a commercial antibody test appear to have substantial immunity to SARS-CoV-2, which means they may be at lower risk for future infection,' said lead author Dr Lynne Penberthy, and associate director of NCI's Surveillance Research Program.
For the study, published in JAMA Internal Medicine, the team looked at data from more than 3.2 million U.S. adults who underwent a COVID-19 antibody test between January 2020 and August 2020.RELATED ARTICLES
- FDA analysis finds Johnson & Johnson's single-dose vaccine... 'The devil is already here': Scientists say homegrown...
Of the tests, 11.6 percent, more than than 378,000, tested positive for antibodies, and the remaining 88.4 percent, more than 2.8 million tested negative.
Over a follow-up period of at least 90 days, researchers looked at the data to see how many people had tested positive for coronavirus infection.
The team noted that a positive antibody test within 30 days of the first test may be caused by a person shedding the virus still
However, most viral shedding is expected to end after 90 days, so a positive result after three months would likely indicate a new infection.
They found that 0.3 percent of all people who tested positive for antibodies were reinfected with COVID-19 in comparison with three percent of people who tested positive for the first time and did not have antibodies.
'The results from the study are basically a 10-fold reduction, but I would have caveats around that,' co-author Dr Douglas Lowy, principal deputy director of the National Cancer Institute, told CNN.
'In other words, it could be an overestimate of the reduction. It could be an underestimate of the reduction.
'To me, the big message is: there's a reduction. The main takeaway is that being antibody positive after natural infection is associated with partial protection against a new infection.'
The authors say they are heartened by the results but that future studies are needed including how long protection lasts and if wanes over time.
In addition, the study did not compare whether people who were reinfected has high or low levels of antibodies from their fist infections.
'Additional research is needed to understand how long this protection lasts, who may have limited protection, and how patient characteristics, such as comorbid conditions, may impact protection,' Penberthy said.
'We are nevertheless encouraged by this early finding.'Read more:
- Covid-19 antibodies may protect against reinfection later, study suggests - CNN
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection | Infectious Diseases | JAMA Internal Medicine | JAMA Network